CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-08 | Treco Douglas A Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-08 | High Katherine A Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-08 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-08 | Fleming Harold Edward Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-08 | Fardis Maria Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Option exercise 10b5-1 | +25,000 | $19.12 | $478K | 412,377 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −7,301 | $63.61 | $464K | 405,076 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −5,999 | $64.46 | $387K | 399,077 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −9,300 | $65.63 | $610K | 389,777 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −2,400 | $66.83 | $160K | 387,377 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 79,582 | ||
| 2023-05-24 | Morrow Phuong Khanh Chief Medical Officer | Shares withheld for taxes | −2,527 | $65.91 | $167K | 4,411 |
| 2023-05-23 | Morrow Phuong Khanh Chief Medical Officer | Option exercise | +6,938 | 6,938 | ||
| 2023-05-23 | Morrow Phuong Khanh Chief Medical Officer | Option exercise · Restricted Stock Units | +6,938 | 20,812 | ||
| 2023-04-25 | Kulkarni Samarth Chief Executive Officer | Option exercise 10b5-1 | +25,000 | $19.12 | $478K | 412,377 |
| 2023-04-25 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −20,607 | $50.50 | $1.0M | 391,770 |
| 2023-04-25 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −4,393 | $51.45 | $226K | 387,377 |
| 2023-04-25 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 104,582 | ||
| 2023-03-29 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | $19.12 | $478K | 412,377 |
Page 16 of 46 · 910 trades